Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 488

1.

Determining the phase diagram of atomically thin layered antiferromagnet CrCl3.

Wang Z, Gibertini M, Dumcenco D, Taniguchi T, Watanabe K, Giannini E, Morpurgo AF.

Nat Nanotechnol. 2019 Nov 11. doi: 10.1038/s41565-019-0565-0. [Epub ahead of print]

PMID:
31712666
2.

Ramucirumab as a second-line treatment for hepatocellular carcinoma: reaching out further to patients with elevated alpha-fetoprotein.

Giannini EG, Trevisani F.

Hepatobiliary Surg Nutr. 2019 Oct;8(5):515-518. doi: 10.21037/hbsn.2019.04.19. No abstract available.

3.

Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice.

Giannini EG, Aglitti A, Borzio M, Gambato M, Guarino M, Iavarone M, Lai Q, Levi Sandri GB, Melandro F, Morisco F, Ponziani FR, Rendina M, Russo FP, Sacco R, Viganò M, Vitale A, Trevisani F; Associazione Italiana per lo Studio del Fegato (AISF) HCC Special Interest Group.

Cancers (Basel). 2019 Oct 30;11(11). pii: E1689. doi: 10.3390/cancers11111689. Review.

4.

Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics.

Lai Q, Vitale A, Manzia TM, Foschi FG, Levi Sandri GB, Gambato M, Melandro F, Russo FP, Miele L, Viganò L, Burra P, Giannini EG; Associazione Italiana per lo Studio del Fegato (AISF) HCC Special Interest Group.

Cancers (Basel). 2019 Oct 15;11(10). pii: E1568. doi: 10.3390/cancers11101568. Review.

5.

High anti-TNF alfa drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel disease.

Bodini G, Demarzo MG, Saracco M, Coppo C, De Maria C, Baldissarro I, Savarino E, Savarino V, Giannini EG.

Scand J Gastroenterol. 2019 Oct;54(10):1220-1225. doi: 10.1080/00365521.2019.1666914. Epub 2019 Sep 25.

PMID:
31553630
6.

A simple protocol to characterize bacterial cell-envelope lipoproteins in a native-like environment.

Giannini E, González LJ, Vila AJ.

Protein Sci. 2019 Nov;28(11):2004-2010. doi: 10.1002/pro.3728. Epub 2019 Oct 14.

PMID:
31518027
7.

Regression of Fibrosis After Direct-acting Antivirals Treatment of Patients with Hepatitis C Virus Cirrhosis: Transposability to Nondecompensated Patients.

Giannini EG, Crespi M, Demarzo M, Bodini G, Furnari M, Marabotto E, Torre F.

J Clin Exp Hepatol. 2019 Jul-Aug;9(4):546. doi: 10.1016/j.jceh.2018.10.007. Epub 2018 Nov 8. No abstract available.

PMID:
31516272
8.

Aminopyrine breath test predicts liver-related events and death in HCV-related cirrhosis on SVR after DAA therapy.

Petta S, Rini F, Calvaruso V, Cammà C, Ciminnisi S, Di Marco V, Giannini EG, Grimaudo S, Maria Pipitone R, Craxì A.

Liver Int. 2019 Sep 11. doi: 10.1111/liv.14250. [Epub ahead of print]

PMID:
31507057
9.

A randomized, 6-wk trial of a low FODMAP diet in patients with inflammatory bowel disease.

Bodini G, Zanella C, Crespi M, Lo Pumo S, Demarzo MG, Savarino E, Savarino V, Giannini EG.

Nutrition. 2019 Jul 1;67-68:110542. doi: 10.1016/j.nut.2019.06.023. [Epub ahead of print]

PMID:
31470260
10.

Arabidopsis thaliana Hcc1 is a Sco-like metallochaperone for CuA assembly in Cytochrome c Oxidase.

Llases ME, Lisa MN, Morgada MN, Giannini E, Alzari PM, Vila AJ.

FEBS J. 2019 Jul 26. doi: 10.1111/febs.15016. [Epub ahead of print]

PMID:
31348612
11.

The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study.

Vitale A, Farinati F, Pawlik TM, Frigo AC, Giannini EG, Napoli L, Ciccarese F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Sacco R, Cabibbo G, Virdone R, Marra F, Felder M, Morisco F, Benvegnù L, Gasbarrini A, Svegliati-Baroni G, Foschi FG, Missale G, Masotto A, Nardone G, Colecchia A, Bernardi M, Trevisani F, Cillo U.

Liver Int. 2019 Aug;39(8):1478-1489. doi: 10.1111/liv.14154. Epub 2019 Jun 26.

PMID:
31131974
12.

Morphological evaluation of sympathetic renal innervation in patients with autosomal dominant polycystic kidney disease.

Rovella V, Scimeca M, Giannini E, D'Ercole A, Giacobbi E, Noce A, D'Urso G, Anselmo A, Bove P, Santeusanio G, Bonanno E, Casasco M, Mauriello S, Di Daniele N, Mauriello A, Anemona L.

J Nephrol. 2019 Apr 25. doi: 10.1007/s40620-019-00612-3. [Epub ahead of print]

PMID:
31025246
13.

Probing magnetism in 2D materials at the nanoscale with single-spin microscopy.

Thiel L, Wang Z, Tschudin MA, Rohner D, Gutiérrez-Lezama I, Ubrig N, Gibertini M, Giannini E, Morpurgo AF, Maletinsky P.

Science. 2019 Jun 7;364(6444):973-976. doi: 10.1126/science.aav6926. Epub 2019 Apr 25.

PMID:
31023891
14.

Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteria.

Ravaioli M, Odaldi F, Cucchetti A, Trevisani F, Piscaglia F, De Pace V, Bertuzzo VR, Neri F, Golfieri R, Cappelli A, D'Errico A, Cescon M, Del Gaudio M, Fallani G, Siniscalchi A, Morelli MC, Ciccarese F, Di Marco M, Farinati F, Giannini EG, Pinna AD.

Sci Rep. 2019 Mar 7;9(1):3781. doi: 10.1038/s41598-019-40543-4.

15.

Micro-elimination of hepatitis C virus infection in β-Thalassaemia major patients: Positively moving towards the World Health Organisation 2030 eradication goal.

Giannini EG, Aghemo A.

Dig Liver Dis. 2019 Apr;51(4):568-569. doi: 10.1016/j.dld.2019.01.001. Epub 2019 Jan 14. No abstract available.

PMID:
30691776
16.

GC-MS and HS-SPME-GC×GC-TOFMS Determination of the Volatile Composition of Essential Oils and Hydrosols (By-Products) from Four Eucalyptus Species Cultivated in Tuscany.

Ieri F, Cecchi L, Giannini E, Clemente C, Romani A.

Molecules. 2019 Jan 9;24(2). pii: E226. doi: 10.3390/molecules24020226.

17.

Improvement in Waldenström's Macroglobulinemia after Successful Treatment of HCV with Direct-acting Antivirals.

Crespi M, Demarzo MG, Brunacci M, Pellegatta G, Ferrando F, Ballestrero A, Grillo F, Savarino V, Giannini EG.

Ann Hepatol. 2018 Oct 16;17(6):1072-1077. doi: 10.5604/01.3001.0012.7208. Review.

18.

Reproducibility and Transportability of the Absence of Incremental Infectious Adverse Events in Patients With Higher Anti-TNF Drug Levels.

Giannini EG, Demarzo MG, Bodini G.

Inflamm Bowel Dis. 2019 Jun 18;25(7):e73. doi: 10.1093/ibd/izy390. No abstract available.

PMID:
30597035
19.

Microfocus Laser-Angle-Resolved Photoemission on Encapsulated Mono-, Bi-, and Few-Layer 1T'-WTe2.

Cucchi I, Gutiérrez-Lezama I, Cappelli E, McKeown Walker S, Bruno FY, Tenasini G, Wang L, Ubrig N, Barreteau C, Giannini E, Gibertini M, Tamai A, Morpurgo AF, Baumberger F.

Nano Lett. 2019 Jan 9;19(1):554-560. doi: 10.1021/acs.nanolett.8b04534. Epub 2018 Dec 27.

PMID:
30570259
20.

Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study.

Pinato DJ, Allara E, Chen TY, Trevisani F, Minguez B, Zoli M, Harris M, Dalla Pria A, Merchante N, Platt H, Jain M, Caturelli E, Kikuchi L, Pineda J, Nelson M, Farinati F, Rapaccini GL, Aytaman A, Yin M, Tan CK, Bower M, Giannini EG, Bräu N; Liver Cancer in HIV and ITA.LI.CA Study Groups.

J Clin Oncol. 2019 Feb 1;37(4):296-304. doi: 10.1200/JCO.18.00885. Epub 2018 Dec 18.

21.

Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals.

Giannini EG, Crespi M, Demarzo M, Bodini G, Furnari M, Marabotto E, Torre F, Zentilin P, Savarino V.

Eur J Clin Invest. 2019 Mar;49(3):e13056. doi: 10.1111/eci.13056. Epub 2018 Dec 19.

PMID:
30474209
22.

Successful DAA Treatment and Global Improvement in a Cirrhotic Patient with Concomitant HCV Infection and Autoimmune Hepatitis.

De Maria C, Ghidotti I, Grillo F, Giannini EG.

Dig Dis Sci. 2019 Feb;64(2):591-593. doi: 10.1007/s10620-018-5356-1. Epub 2018 Nov 1. No abstract available.

PMID:
30386944
23.

Acquired Hepatocerebral Degeneration in the Absence of Portosystemic Shunting.

Caranci G, Cordano C, Giannini E, Bandini F.

J Clin Neurol. 2019 Jan;15(1):128-129. doi: 10.3988/jcn.2019.15.1.128. Epub 2018 Oct 26. No abstract available.

24.

Harmonising proton pump inhibitors treatment in the specialist setting following the SIGE recommendations.

Crespi M, Ghidotti I, Bodini G, Furnari M, Marabotto E, Giannini EG.

Dig Liver Dis. 2019 Jan;51(1):173-174. doi: 10.1016/j.dld.2018.09.025. Epub 2018 Oct 1. No abstract available.

PMID:
30366811
25.

The Reaction Mechanism of Metallo-β-Lactamases Is Tuned by the Conformation of an Active-Site Mobile Loop.

Palacios AR, Mojica MF, Giannini E, Taracila MA, Bethel CR, Alzari PM, Otero LH, Klinke S, Llarrull LI, Bonomo RA, Vila AJ.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01754-18. doi: 10.1128/AAC.01754-18. Print 2019 Jan.

26.

Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Minutolo R, Aghemo A, Chirianni A, Fabrizi F, Gesualdo L, Giannini EG, Maggi P, Montinaro V, Paoletti E, Persico M, Perticone F, Petta S, Puoti M, Raimondo G, Rendina M, Zignego AL; Italian Society of Nephrology (SIN), the Italian Association for the Study of the Liver (AISF), the Italian Society of Infectious and Tropical Disease (SIMIT), the Italian Society of Internal Medicine (SIMI).

Dig Liver Dis. 2018 Nov;50(11):1133-1152. doi: 10.1016/j.dld.2018.08.022. Epub 2018 Sep 12.

PMID:
30266305
27.

Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Minutolo R, Aghemo A, Chirianni A, Fabrizi F, Gesualdo L, Giannini EG, Maggi P, Montinaro V, Paoletti E, Persico M, Perticone F, Petta S, Puoti M, Raimondo G, Rendina M, Zignego AL; Italian Society of Nephrology (SIN); Italian Association for the Study of the Liver (AISF); Italian Society of Infectious and Tropical Disease (SIMIT); Italian Society of Internal Medicine (SIMI).

Intern Emerg Med. 2018 Dec;13(8):1139-1166. doi: 10.1007/s11739-018-1940-9. Epub 2018 Sep 25.

PMID:
30255464
28.

Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Minutolo R, Aghemo A, Chirianni A, Fabrizi F, Gesualdo L, Giannini EG, Maggi P, Montinaro V, Paoletti E, Persico M, Perticone F, Petta S, Puoti M, Raimondo G, Rendina M, Zignego AL; Italian Society of Nephrology (SIN); Italian Association for the Study of the Liver (AISF); Italian Society of Infectious and Tropical Disease (SIMIT); Italian Society of Internal Medicine (SIMI).

J Nephrol. 2018 Oct;31(5):685-712. doi: 10.1007/s40620-018-0523-1. Epub 2018 Sep 25.

PMID:
30255440
29.

Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Minutolo R, Aghemo A, Chirianni A, Fabrizi F, Gesualdo L, Giannini EG, Maggi P, Montinaro V, Paoletti E, Persico M, Perticone F, Petta S, Puoti M, Raimondo G, Rendina M, Zignego AL; Italian Society of Nephrology (SIN); Italian Association for the Study of the Liver (AISF); Italian Society of Infectious and Tropical Disease (SIMIT); Italian Society of Internal Medicine (SIMI).

Infection. 2019 Feb;47(1):141-168. doi: 10.1007/s15010-018-1209-2. Epub 2018 Sep 25.

PMID:
30255389
30.

The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin.

Furnari M, De Alessandri A, Cresta F, Haupt M, Bassi M, Calvi A, Haupt R, Bodini G, Ahmed I, Bagnasco F, Giannini EG, Casciaro R.

J Gastroenterol. 2019 Mar;54(3):261-270. doi: 10.1007/s00535-018-1509-4. Epub 2018 Sep 19.

PMID:
30232597
31.

NASH-related and cryptogenic cirrhosis similarities extend beyond cirrhosis.

Giannini EG, Bodini G, Furnari M, Marabotto E.

J Hepatol. 2018 Oct;69(4):972-973. doi: 10.1016/j.jhep.2018.05.016. Epub 2018 Jul 4. No abstract available.

PMID:
30227919
32.

Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.

Hinze CH, Foell D, Johnson AL, Spalding SJ, Gottlieb BS, Morris PW, Kimura Y, Onel K, Li SC, Grom AA, Taylor J, Brunner HI, Huggins JL, Nocton JJ, Haines KA, Edelheit BS, Shishov M, Jung LK, Williams CB, Tesher MS, Costanzo DM, Zemel LS, Dare JA, Passo MH, Ede KC, Olson JC, Cassidy EA, Griffin TA, Wagner-Weiner L, Weiss JE, Vogler LB, Rouster-Stevens KA, Beukelman T, Cron RQ, Kietz D, Schikler K, Mehta J, Ting TV, Verbsky JW, Eberhard AB, Huang B, Giannini EH, Lovell DJ.

Arthritis Rheumatol. 2019 Mar;71(3):451-459. doi: 10.1002/art.40727. Epub 2019 Jan 24.

PMID:
30225949
33.

Bleeding after paracentesis in patients with decompensated cirrhosis and acute kidney injury: The perfect storm.

Giannini EG, Bodini G, Furnari M, Marabotto E.

Liver Int. 2018 Nov;38(11):2101. doi: 10.1111/liv.13962. Epub 2018 Oct 8. No abstract available.

PMID:
30223302
34.

Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis.

Guarino M, Viganò L, Ponziani FR, Giannini EG, Lai Q, Morisco F; Special Interest Group on Hepatocellular carcinoma and new anti-HCV therapies” of the Italian Association for the Study of the Liver.

Dig Liver Dis. 2018 Nov;50(11):1105-1114. doi: 10.1016/j.dld.2018.08.001. Epub 2018 Aug 11. Review.

PMID:
30170908
35.

Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients.

Giannini EG, Giambruno E, Brunacci M, Plaz Torres MC, Furnari M, Bodini G, Zentilin P, Savarino V.

Ann Hepatol. 2018 Jun 5;17(5):830-835. doi: 10.5604/01.3001.0012.0775.

36.

Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study.

Vitale A, Farinati F, Noaro G, Burra P, Pawlik TM, Bucci L, Giannini EG, Faggiano C, Ciccarese F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Sacco R, Cabibbo G, Virdone R, Marra F, Felder M, Morisco F, Benvegnù L, Gasbarrini A, Svegliati-Baroni G, Foschi FG, Olivani A, Masotto A, Nardone G, Colecchia A, Fornari F, Marignani M, Vicari S, Bortolini E, Cozzolongo R, Grasso A, Aliberti C, Bernardi M, Frigo AC, Borzio M, Trevisani F, Cillo U; Italian Liver Cancer (ITA.LI.CA) group.

Hepatology. 2018 Oct;68(4):1232-1244. doi: 10.1002/hep.30185.

PMID:
30048016
37.

Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score.

Carbone M, Nardi A, Flack S, Carpino G, Varvaropoulou N, Gavrila C, Spicer A, Badrock J, Bernuzzi F, Cardinale V, Ainsworth HF, Heneghan MA, Thorburn D, Bathgate A, Jones R, Neuberger JM, Battezzati PM, Zuin M, Taylor-Robinson S, Donato MF, Kirby J, Mitchell-Thain R, Floreani A, Sampaziotis F, Muratori L, Alvaro D, Marzioni M, Miele L, Marra F, Giannini E, Gaudio E, Ronca V, Bonato G, Cristoferi L, Malinverno F, Gerussi A, Stocken DD, Cordell HJ, Hirschfield GM, Alexander GJ, Sandford RN, Jones DE, Invernizzi P, Mells GF; Italian PBC Study Group and the UK–PBC Consortium.

Lancet Gastroenterol Hepatol. 2018 Sep;3(9):626-634. doi: 10.1016/S2468-1253(18)30163-8. Epub 2018 Jul 13.

38.

Reduction in TIMP-2 serum levels predicts remission of inflammatory bowel diseases.

Carbone F, Bodini G, Brunacci M, Bonaventura A, Vecchiè A, Liberale L, Crespi M, Baldissarro I, Dallegri F, Savarino V, Montecucco F, Giannini EG.

Eur J Clin Invest. 2018 Oct;48(10):e13002. doi: 10.1111/eci.13002. Epub 2018 Aug 6.

PMID:
30011062
39.

Pediatric Rheumatology Collaborative Study Group - over four decades of pivotal clinical drug research in pediatric rheumatology.

Brunner HI, Rider LG, Kingsbury DJ, Co D, Schneider R, Goldmuntz E, Onel KB, Giannini EH, Lovell DJ; PRCSG Advisory Council.

Pediatr Rheumatol Online J. 2018 Jul 11;16(1):45. doi: 10.1186/s12969-018-0261-x. Review.

40.

Very large tunneling magnetoresistance in layered magnetic semiconductor CrI3.

Wang Z, Gutiérrez-Lezama I, Ubrig N, Kroner M, Gibertini M, Taniguchi T, Watanabe K, Imamoğlu A, Giannini E, Morpurgo AF.

Nat Commun. 2018 Jun 28;9(1):2516. doi: 10.1038/s41467-018-04953-8.

41.

A Closer Look at Factors Associated With Bleeding in Cirrhotic Patients.

Giannini EG, Bodini G, Furnari M, Marabotto E.

Am J Gastroenterol. 2019 Feb;114(2):364-365. doi: 10.1038/s41395-018-0128-2. No abstract available.

PMID:
29910461
42.

Correction: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma.

Giannini EG, Moscatelli A, Pellegatta G, Vitale A, Farinati F, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Cabibbo G, Felder M, Sacco R, Morisco F, Missale G, Foschi FG, Gasbarrini A, Baroni GS, Virdone R, Masotto A, Trevisani F; Italian Liver Cancer (ITA.LI.CA) Group.

Am J Gastroenterol. 2018 Jul;113(7):1100. doi: 10.1038/s41395-018-0131-7.

PMID:
29910460
43.

Letter: it is time to adopt new objective parameters to accurately identify patients with functional heartburn.

Marabotto E, Furnari M, Giannini EG, Savarino V, Savarino E.

Aliment Pharmacol Ther. 2018 Jul;48(1):107-108. doi: 10.1111/apt.14800. No abstract available.

PMID:
29882977
44.

Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients.

Carr BI, Giannelli G, Guerra V, Giannini EG, Farinati F, Rapaccini GL, Marco MD, Zoli M, Caturelli E, Masotto A, Virdone R, Sacco R, Trevisani F.

Int J Biol Markers. 2018 Nov;33(4):423-431. doi: 10.1177/1724600818776838. Epub 2018 Jun 6.

PMID:
29874983
45.

Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis.

Ascione A, De Luca M, Melazzini M, Montilla S, Trotta MP, Petta S, Puoti M, Sangiovanni V, Messina V, Bruno S, Izzi A, Villa E, Aghemo A, Zignego AL, Orlandini A, Fontanella L, Gasbarrini A, Marzioni M, Giannini EG, Craxì A; ABACUS Study Group.

Infection. 2018 Oct;46(5):607-615. doi: 10.1007/s15010-018-1157-x. Epub 2018 May 28.

PMID:
29808463
46.

Metabolic disorders across hepatocellular carcinoma in Italy.

Morisco F, Guarino M, Valvano MR, Auriemma F, Farinati F, Giannini EG, Ciccarese F, Tovoli F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Sacco R, Cabibbo G, Felder M, Benvengù L, Gasbarrini A, Svegliati Baroni G, Foschi FG, Biasini E, Masotto A, Virdone R, Marra F, Caporaso N, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group.

Liver Int. 2018 Nov;38(11):2028-2039. doi: 10.1111/liv.13877. Epub 2018 Jun 19.

PMID:
29745475
47.

Radiological, Histological and Chemical Analysis of Breast Microcalcifications: Diagnostic Value and Biological Significance.

Bonfiglio R, Scimeca M, Toschi N, Pistolese CA, Giannini E, Antonacci C, Ciuffa S, Tancredi V, Tarantino U, Albonici L, Bonanno E.

J Mammary Gland Biol Neoplasia. 2018 Jun;23(1-2):89-99. doi: 10.1007/s10911-018-9396-0. Epub 2018 May 9.

PMID:
29744755
48.

Local Real-Space View of the Achiral 1T-TiSe_{2} 2×2×2 Charge Density Wave.

Hildebrand B, Jaouen T, Mottas ML, Monney G, Barreteau C, Giannini E, Bowler DR, Aebi P.

Phys Rev Lett. 2018 Mar 30;120(13):136404. doi: 10.1103/PhysRevLett.120.136404.

PMID:
29694190
49.

Specific issues concerning the management of patients on the waiting list and after liver transplantation.

Burra P, Giannini EG, Caraceni P, Ginanni Corradini S, Rendina M, Volpes R, Toniutto P.

Liver Int. 2018 Aug;38(8):1338-1362. doi: 10.1111/liv.13755. Epub 2018 May 16. Review.

PMID:
29637743
50.

Long-Term Follow-Up Study of Liver-Related Outcome After Bilio-Pancreatic Diversion in Patients with Initial, Significant Liver Damage.

Giannini EG, Coppo C, Romana C, Camerini GB, De Cian F, Scopinaro N, Papadia FS.

Dig Dis Sci. 2018 Jul;63(7):1946-1951. doi: 10.1007/s10620-018-5052-1. Epub 2018 Apr 9.

PMID:
29629490

Supplemental Content

Loading ...
Support Center